Search Follow us

Fluence Corporation (FLC)

Business description

Fluence is a global supplier of water and wastewater treatment solutions. Its decentralised products provide municipal customers with ‘plug and play’ solutions that are both quicker to deploy and substantially cheaper than traditional alternatives.

Y/E Dec Revenue (US$m) EBITDA (US$m) PBT (US$m) EPS (c) P/E (x) P/CF (x)
2016A 0.8 (8.8) (9.1) (4.27) N/A N/A
2017A 33.2 (23.6) (21.7) (7.00) N/A N/A
2018E 107.0 (13.8) (12.6) (2.90) N/A N/A
2019E 154.0 (2.0) (4.1) (0.95) N/A N/A

Last updated on 03/10/2018

Latest research

Investment summary

Fluence has secured a deal for its Aspiral product in China that should generate at least US$45m in revenue over the next three years. This deal is significant as, aside from the financial benefit, it demonstrates the size of the opportunity for Aspiral in China. Greater investor confidence in Fluence’s prospects here could drive a sharp re-rating of the shares, in our view. We make no changes to numbers now but will review estimates after the Q3 trading statement.

Last updated on 15/10/2018

Key management

Henry Charrabe, CEO
Richard Irving, Executive Chairman

Company address

Level 3, 62 Lygon Street, Carlton
View website